(2R)-2-acetamido-3-[(2-ethylphenyl)carbamothioylsulfanyl]propanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2R)-2-acetamido-3-[(2-ethylphenyl)carbamothioylsulfanyl]propanoic acid
• 化学式: C₁₄H₁₈N₂O₃S₂
• 分子量: 326.4
• InChiKey: QQALRJMJJNDQET-LBPRGKRZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  21
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  136
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• US20140274965A1
  申请人：——

  公开号：US20140274965A1

  公开（公告）日：2014-09-18
• US20140274966A1
  申请人：——

  公开号：US20140274966A1

  公开（公告）日：2014-09-18
• Drink Product and Use Thereof
  申请人：HYGIA PHARMACEUTICALS, LLC

  公开号：US20160030455A1

  公开（公告）日：2016-02-04

  A drink product having pharmaceutical compositions as an active ingredients of at least one phosphorylated inositol, optionally Genistein, optionally Ubiquinol, and optionally additional unphosphorylated inositol. Uses for prevention, treatment, and reduction in risk of developing or progression of a number of conditions are disclosed. This invention relates to certain drink products that generally are aqueous solutions containing Genistein (optionally), at least one phosphorylated myoinositol having 1 to 9 phosphate groups (and/or any of the optical isomers thereof) optionally enriched with any or all of myoinositol, optical isomers of myoinositol, electrolytes, flavors, vitamins, free radical scavengers, and sweeteners.
• DRINK PRODUCT CONTAINING GENISTEIN AND USE THEREOF
  申请人：HYGIA PHARMACEUTICALS, LLC

  公开号：US20210275550A1

  公开（公告）日：2021-09-09

  A drink product having as an active ingredient genistein and an inositol hexaphosphate and/or an unphosphorylated inositol and optionally additional inositol (unphosphorylated as well as hexaphosphorylated) moieties. Hexaphosphates for use in the invention include myoinositol hexaphosphate and/or any of the other 8 optical isomers thereof. The optional additional inositols include myoinositol and/or any of the other 8 optical isomers thereof. Uses for prevention, treatment, and reduction in risk of developing or progression of a number of conditions are disclosed.
• DRINK PRODUCT AND USE THEREOF
  申请人：HYGIA PHARMACEUTICALS, LLC

  公开号：US20210369745A1

  公开（公告）日：2021-12-02

  A drink product having pharmaceutical compositions as an active ingredients of, at least one phosphorylated inositol, optionally Genistein, optionally Ubiquinol, and optionally additional unphosphorylated inositol. Uses for prevention, treatment, and reduction in risk of developing or progression of a number of conditions are disclosed.